fashion -WSS

fashion

author：knowledge 2025-09-29 07:50:04 - browse：227

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Spinal cord stimulation reduces pain in amputees, study finds

WSS

Sarepta Duchenne therapy fails to meet primary endpoint in trial

The health care issue Democrats can’t solve: hospital reform

Pharma patents targeted by Biden in move to slash drug prices

Kidney transplant patients stopped immunosuppressants in trial

SCOTUS to consider access to abortion pill mifepristone

Life sciences investors close nearly $6 billion in new funds

focus

fashion

Sign up for D.C. Diagnosis

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

The woman behind the Dana Farber

Activists slam private health insurers over coverage restrictions

Inari Medical to buy amputation prevention company LimFlow

Guidelines to prevent youth baseball injuries need more muscle

Travis Kelce and the trap of celebrity vaccine endorsements

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

Medical records are filled with copy

Travis Kelce and the trap of celebrity vaccine endorsements

hotspot

Brain injuries and the importance of a second opinion

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Bill would allow buprenorphine prescription for addiction via telehealth

All of Us, NIH's precision medicine initiative, gets a big boost

STAT letters to the editor on burnt

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Wikipedia

focus

focus

entertainment